Suppr超能文献

慢性酒精性肝病中的乙醛脱氢酶(酶委员会编号1.2.1.3)

Aldehyde dehydrogenase (E.C. 1.2.1.3) in chronic alcoholic liver diseases.

作者信息

Nilius R, Zipprich B, Krabbe S

出版信息

Hepatogastroenterology. 1983 Aug;30(4):134-6.

PMID:6629303
Abstract

Acetaldehyde dehydrogenase (ALDH) activity in liver biopsy specimens was considerably reduced in alcoholic cirrhosis (n = 5), elevated in alcoholic fatty liver (n = 11)--probably due to enzyme induction--only slightly elevated in alcoholic hepatitis (n = 6), but unaffected in non-alcoholic liver diseases (n = 23) in comparison with specimens obtained from patients with minimal liver lesions. We will argue as a working hypothesis that alcoholics with induced ALDH activity will mainly develop fatty liver, whereas reduced hepatic ALDH appears to be a reason for elevated acetaldehyde levels followed by additional liver injury and progression at least for alcoholic cirrhosis.

摘要

与肝损伤最小的患者的活检样本相比,酒精性肝硬化患者(n = 5)肝活检样本中的乙醛脱氢酶(ALDH)活性显著降低,酒精性脂肪肝患者(n = 11)的该活性升高——可能是由于酶诱导——酒精性肝炎患者(n = 6)的该活性仅略有升高,而非酒精性肝病患者(n = 23)的该活性未受影响。我们将提出一个工作假设,即ALDH活性被诱导的酗酒者主要会发展为脂肪肝,而肝脏ALDH活性降低似乎是乙醛水平升高的一个原因,进而导致额外的肝损伤,并至少会促使酒精性肝硬化病情进展。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验